DNA Damage Response Market: Industry Trends and Global Forecasts, till 2030 – Distribution by Target Disease Indication (Acute Myeloid Leukemias, COVID-19, Diabetic Macular Edemas, Mesotheliomas, Myelodysplastic Syndromes, Non-Squamous Non-Small Cell Lung Cancers, Prostate Cancers, Uterine Serous Carcinomas), Therapeutic Area (Hematological Malignancies, Solid Tumors, and Other Disorders), Target Molecule (APE1/Ref-1, Casein Kinase 2, CHK-1, C-Tak, DHODH, MAPKAPK2, p53, and WEE 1), Type of Molecule (Biologics and Small Molecule), Route of Administration (Oral Drugs and Intravenous Drugs), and by Key Geographical Regions (US, Canada, Denmark, France, Germany, Italy, Spain, UK, Australia, Singapore, and South Korea)